Prospects for New Cannabis-based prescription medicines

Cannabis Therapeutics in HIV/AIDS

Volumn , Issue , 2012, Pages 183-206

  Whittle, Brian A ^a   Guy, Geoffrey W ^a   Robson, Philip ^a  

^a Porton Down Science Park   (United Kingdom)

Author keywords

Alternative delivery systems; Botanical extracts; Cannabinoids; Cannabis; CB receptors; Clinical research; Harm reduction; Multiple sclerosis; Neurogenic pain; New chemovars; Secure dispensing; Spinal cord injury

Indexed keywords

EID: 85071469090     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Adams, M.D., J.T. Earnhardt, B.R. Martin, L.S. Harris, W.L. Dewey, and R.K. Razdan. 1977. A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia 33:1204-1205
2. Burstein, S. and A. Raz. 1972. Inhibition of prostaglandin E2 biosynthesis by D1-tetrahydrocannabinol. Prostaglandins 2:369-375
3. Brown, D.T. 1998. Cannabis: The genus Cannabis. Amsterdam: Harwood Academic Publishers
4. Carlini E.A., J.R. Leiter, M. Tannhauser, and A.C.Berardi. 1973. Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol 25:664-665
5. Davis, K.H., I.A. McDaniel, Jr., et al. 1984. Some smoking characteristics of marijuana cigarettes. In Stig, W.L. Dewey, R.E. Agurell. The cannabinoids: Chemical, pharmacologic and therapeutic aspects. San Diego, CA: Academic Press
6. De Meijer, E.P.M., and L.C.P. Keizer. 1996. Patterns of diversity in Cannabis. Genet Resourc Crop Evolut 43:41-52
7. Guy, G.W., B.A. Whittle and M.J. Grey. 2000a. Dose dispensing Apparatus. GB Pat Application 25809.5, Oct 20, 2000
8. Guy, G.W., B.A. Whittle and M.J. Grey. 2000b. Secure dispensing of materials. GB Patent Application 25811.1, Oct 20, 2000
9. Hampson, A.J., M. Grimaldi, J. Axelrod, and D. Wink. 1998. Cannabidiol and (-) 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Nat Acad Sci 95: 8268-8273
10. Hardy, J.G., S.P. Newman, and M. Knoch. 1993. Lung deposition from four nebulizers. Resp Med 87: 461-465
11. House of Lords Science and Technology Sub Committee report. 2001. The development of prescription cannabis-based medicines (Jan 2001)
12. In-house Report GPA 002/000159. 2000. CBD Primary Screening Program
13. Iversen, L.L. 2000. The science of marijuana. Oxford: Oxford University Press
14. Mechoulam, R. (ed.) 1976. Cannabinoids as therapeutic agents. Boca Raton, FL: CRC Press
15. Merck index: An encyclopedia of chemicals, drugs, and biologicals. 1996. S. Budavari, and M.J. O'Neil (Eds.), 12th Edition, Boca Raton, FL: CRC Press
16. Merck's manual. 1899. Part 1, p. 26
17. Pate, D. 1997. US Patent Application Number 08/919317, 28 August 1997
18. Pertwee, R.G. 1998. Advances in cannabinoid receptor pharmacology in cannabis. pp. 125-174, in D.T. Brown ( Ed. ). Cannabis: The genus Cannabis. Amsterdam: Harwood Academic Publishers
19. Petro, D.J. 1980. Marijuana as a therapeutic agent for muscle spasm or spasticity. Psychosom 21(1):81-85
20. Price, M.A.P., and W.G. Notcutt. 1998. Cannabis in pain relief. pp. 223-246. In D.T. Brown (Ed.). Cannabis: The genus Cannabis. Amsterdam: Harwood Academic Publishers
21. Raman, A. 1998. The cannabis plant: Botany, cultivation and processing for use. pp. 29-54. In D.T. Brown ( Ed. ). Cannabis: The genus Cannabis. Amsterdam: Harwood Publishers
22. Ram, H.Y.M., and R. Sett. 1982. Reversal of ethephon-induced feminization in male plants of cannabis by ethylene antagonists. Zeitschrift fur pflanzenphysiologie 107(1):85-89
23. Samuelsson, G. 1992. Drugs of natural origin. Stockholm, Sweden: Swedish Pharmaceutical Press
24. Smiley, K.A., R. Karber, and S.A. Turkanis. 1976. Effect of cannabinoids on the perfused rat heart. Res Comm Chem Pathol Pharmacol 14:659-675
25. Tashkin, D.P., B.J. Shapiro, and I.M. Frank. 1973. Acute pulmonary and physiological effects of smoked marijuana and oral delta-9-THC in healthy young men. N Eng J Med 289(7):336-341
26. Touitou, E. 1996. US Patent 5,540,934 (July 30, 1996)
27. Touitou, E., B. Fabin, S. Danny, and S. Almog. 1988. Transdermal delivery of tetrahydrocannabinol. Int J Pharmaceut 43:9-15
28. Whittle, B.A., and G.W. Guy. 2001. Formulations for sublingual delivery. GB Patent Application 103638.3, Feb 14, 2001
29. Zuardi, A.W., and F.S. Guimarães. 1997. Cannabidiol as an anxiolytic and antipsychotic. In M.L. Mathre (Ed.), Cannabis in medical practice. Jefferson, NC and London: McFarland & Co. pp. 133-141